Immutep Limited

Immutep Limitedverified

IMMP

Price:

$1.95

Market Cap:

$487.62M

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, which is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003 that is in Phase IIb clinical trial to treat HNSCC; and INSIGHT-004 and INSIGHT-003, which is in a Phase ...[Read more]

Industry

Biotechnology

IPO Date

2012-04-19

Stock Exchange

NASDAQ

Ticker

IMMP

The Current Ratio as of December 2024 (TTM) for Immutep Limited (IMMP) is 13.81

According to Immutep Limited’s latest financial reports and current stock price. The company's current Current Ratio is 13.81. This represents a change of 142.46% compared to the average of 5.70 of the last 4 quarters.

Immutep Limited (IMMP) Historical Current Ratio (quarterly & annually)

How has IMMP Current Ratio performed in the past?

The mean historical Current Ratio of Immutep Limited over the last ten years is 9.34. The current 13.81 Current Ratio has changed 14.68% with respect to the historical average. Over the past ten years (40 quarters), IMMP's Current Ratio was at its highest in in the December 2015 quarter at 15.71. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

9.34

Median

9.08

Minimum

1.83

Maximum

14.72

Immutep Limited (IMMP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Immutep Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 703.63%

Maximum Annual Current Ratio = 14.72

Minimum Annual Increase = -79.44%

Minimum Annual Current Ratio = 1.83

Quarterly (TTM)
Annual
YearCurrent RatioChange
202313.81-2.44%
202214.1610.50%
202112.8138.37%
20209.26108.42%
20194.44-40.23%
20187.4322.90%
20176.05-58.92%
201614.72703.63%
20151.83-79.44%
20148.91-0.29%

Immutep Limited (IMMP) Average Current Ratio

How has IMMP Current Ratio performed in the past?

The current Current Ratio of Immutep Limited (IMMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

13.59

5-year avg

10.90

10-year avg

9.34

Immutep Limited (IMMP) Current Ratio vs. Peers

How is IMMP’s Current Ratio compared to its peers?

Immutep Limited’s Current Ratio is less than CohBar, Inc. (15.69), greater than Ocean Biomedical, Inc. (0.07), less than Elevation Oncology, Inc. (17.77), less than AVROBIO, Inc. (26.17), greater than Zura Bio Limited (10.36), less than CNS Pharmaceuticals, Inc. (0), greater than ZyVersa Therapeutics, Inc. (1.82), less than eFFECTOR Therapeutics, Inc. (33.83), greater than VectivBio Holding AG (1.03), greater than Enveric Biosciences, Inc. (9.14), greater than null (5.17),

Build a custom stock screener for Immutep Limited (IMMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immutep Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immutep Limited (IMMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immutep Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Immutep Limited's Current Ratio?

How is the Current Ratio calculated for Immutep Limited (IMMP)?

What is the highest Current Ratio for Immutep Limited (IMMP)?

What is the 3-year average Current Ratio for Immutep Limited (IMMP)?

What is the 5-year average Current Ratio for Immutep Limited (IMMP)?

How does the current Current Ratio for Immutep Limited (IMMP) compare to its historical average?